Unformatted text preview: over a seven-year period started in 2001. The FDA did not give a timeline for when the program will complete the safety study. © Thomson Reuters 2009. All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters and its logo are registered trademarks or trademarks of the Thomson Reuters group of companies around the world. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests. Page 1 of 1 Reuters.com 12/31/2009 http://www.reuters.com/assets/print?aid=USTRE5BT43520091230...
View Full Document
- Spring '11
- Pharmacology, Prescription drug, Thomson Reuters, Reuters, Food and Drug Administration